In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Acumen Pharmaceuticals Inc (NASDAQ: ABOS) closed the day trading at $1.77 down -4.32% from the previous closing price of $1.85. In other words, the price has decreased by -$4.32 from its previous closing price. On the day, 0.78 million shares were traded. ABOS stock price reached its highest trading level at $1.85 during the session, while it also had its lowest trading level at $1.758.
Ratios:
For a better understanding of ABOS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.43 and its Current Ratio is at 10.43. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on July 26, 2024, initiated with a Buy rating and assigned the stock a target price of $7.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 19 ’24 when OConnell Daniel Joseph sold 15,200 shares for $3.47 per share. The transaction valued at 52,753 led to the insider holds 502,485 shares of the business.
Meisner Derek M sold 8,933 shares of ABOS for $31,048 on Jan 19 ’24. The Chief Legal Officer & Corp Sec now owns 108,867 shares after completing the transaction at $3.48 per share. On Jan 18 ’24, another insider, Zuga Matt, who serves as the CFO & Chief Business Officer of the company, sold 4,242 shares for $3.71 each. As a result, the insider received 15,717 and left with 211,445 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABOS now has a Market Capitalization of 106341248 and an Enterprise Value of -59207412.
Stock Price History:
Over the past 52 weeks, ABOS has reached a high of $5.09, while it has fallen to a 52-week low of $1.72. The 50-Day Moving Average of the stock is -28.52%, while the 200-Day Moving Average is calculated to be -38.67%.
Shares Statistics:
Over the past 3-months, ABOS traded about 239.78K shares per day on average, while over the past 10 days, ABOS traded about 416190 shares per day. A total of 60.08M shares are outstanding, with a floating share count of 45.03M. Insiders hold about 25.05% of the company’s shares, while institutions hold 64.39% stake in the company. Shares short for ABOS as of 1732838400 were 1385196 with a Short Ratio of 5.78, compared to 1730332800 on 1447247. Therefore, it implies a Short% of Shares Outstanding of 1385196 and a Short% of Float of 3.1.
